Blair William & Co. IL Raises Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Blair William & Co. IL boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 33.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,194 shares of the company’s stock after buying an additional 2,288 shares during the period. Blair William & Co. IL’s holdings in Henry Schein were worth $630,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC boosted its stake in Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock worth $186,000 after buying an additional 1,898 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock worth $1,000,000 after buying an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its stake in Henry Schein by 5.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock worth $941,000 after buying an additional 678 shares during the last quarter. GAMMA Investing LLC boosted its stake in Henry Schein by 37.8% during the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock worth $270,000 after buying an additional 1,081 shares during the last quarter. Finally, Wellington Management Group LLP boosted its stake in Henry Schein by 12.6% during the fourth quarter. Wellington Management Group LLP now owns 6,902 shares of the company’s stock worth $478,000 after buying an additional 775 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $65.94 on Monday. The stock’s 50-day moving average is $71.07 and its two-hundred day moving average is $71.06. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a market cap of $8.00 billion, a price-to-earnings ratio of 21.27, a price-to-earnings-growth ratio of 2.17 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%. The company had revenue of $3.24 billion for the quarter, compared to analysts’ expectations of $3.22 billion. During the same quarter last year, the company earned $1.23 EPS. Henry Schein’s revenue for the quarter was up 3.3% compared to the same quarter last year. Analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on HSIC shares. Robert W. Baird reissued a “neutral” rating and set a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Wells Fargo & Company cut their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Barrington Research cut their price objective on Henry Schein from $86.00 to $78.00 and set an “outperform” rating on the stock in a report on Wednesday, August 6th. Finally, JPMorgan Chase & Co. cut their price objective on Henry Schein from $80.00 to $76.00 and set an “overweight” rating on the stock in a report on Thursday. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.